Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.48 (
transcriptase
)
9,479
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
ICAM-5
(telencephalin) is an intercellular adhesion molecule reported to be expressed only in the somatodendritic membrane of telencephalic neurons. We recently identified high
ICAM-5
expression in a cDNA array study of head and neck neoplasms with a propensity for perineural invasion. To determine the association of this gene in tumorigenesis and perineural invasion, we analyzed the expression and functional status of
ICAM-5
mRNA transcripts in 30 different human cancer cell lines and 25 head and neck squamous carcinoma specimens by reverse-
transcriptase
polymerase chain reaction (cell lines and specimens) and in vitro functional assays (cell lines).
ICAM-5
transcripts were detected in 28 (93%) of 30 cell lines derived from primary head and neck, colon, thyroid, cervical, pancreatic, skin, and adenoid cystic carcinomas. In cell lines, small interfering RNA blocked
ICAM-5
expression and inhibited cell proliferation. Treatment with the phosphatidylinositol 3'-kinase (PBK) inhibitor LY294002 resulted in
ICAM-5
down-regulation. In tissue specimens, none of the 25 histologically normal oral mucosal specimens had detectable
ICAM-5
level, whereas 16 (64%) of the 25 matched primary squamous carcinomas showed expression. Carcinoma specimens high
ICAM-5
expression had a high incidence of perineural invasion. Our study indicates that
ICAM-5
may play a role in tumorigenesis and perineural invasion, most likely through the P13K/Akt-signaling pathway.
...
PMID:ICAM-5 (telencephalin) gene expression in head and neck squamous carcinoma tumorigenesis and perineural invasion! 1597 20